Tri-agonist research compound, GLP-1, GIP, glucagon receptor activity.
$90/vial
DOSE
10 MG
UNIT VALUE
0.111 mg per dollar
PURITY (HPLC)
99.6%
BATCH
NLL-RTA-2604
MOLECULAR WEIGHT
5,071.45 Da
SHIPPING
US, USPS Priority
For in vitro research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any condition. US shipping only.
RESEARCH OVERVIEW
Retatrutide is a triple-agonist peptide developed for in vitro research into GLP-1, GIP, and glucagon receptor activity. Each vial contains 10 mg of lyophilized peptide, lab verified at 99.6% purity by HPLC and confirmed by LC-MS.
RECONSTITUTION + STORAGE
RECONSTITUTION
For research reconstitution, 2 mL of bacteriostatic water yields 5 mg/mL. Adjust per research protocol. Do not inject. Not for human consumption.
STORAGE
Store lyophilized vial at room temperature, protected from light. Once reconstituted, refrigerate at 2 to 8 degrees Celsius and use within 28 days.
RESEARCH CITATIONS
Citations are listed for research context only and do not imply efficacy claims for human use.
FAQ
A research peptide that engages GLP-1, GIP, and glucagon receptors. Studied in laboratory contexts only.
Lyophilized in a sealed vial with ice pack and discreet plain packaging. Same-day USPS Priority within the US.
Yes. Every batch is HPLC and LC-MS tested. The latest COA is downloadable from this page.
RECONSTITUTION + DOSING REFERENCE
Enter the BAC water volume and target research dose. The calculator returns concentration, units to draw on a reference syringe, doses per vial, and vial duration. For laboratory research reference only.